Impact of migration from an illicit drug scene on hospital outcomes among people who use illicit drugs in Vancouver, Canada.
hospital outcomes
illicit drugs
migration patterns
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
11
09
2019
revised:
13
04
2020
accepted:
27
04
2020
pubmed:
3
6
2020
medline:
9
11
2021
entrez:
3
6
2020
Statut:
ppublish
Résumé
People who use illicit drugs (PWUD) are vulnerable to an array of negative health outcomes, and increased hospital services utilisation. PWUD are also a transient population which poses challenges to the provision of optimal health care. The objective of this study was to identify out-migration patterns from Vancouver's Downtown Eastside (DTES), a neighbourhood where services for PWUD are concentrated, and to estimate the impact of these patterns on hospitalisation events among PWUD. Data were collected through three prospective cohorts of PWUD in Vancouver, which were linked with health administrative data. Latent class growth analysis was used to define migration trajectory groups. Poisson regression was used to estimate the effect of migration patterns on hospitalisation events. A total of 1180 participants were included in the study. Four latent classes were identified: early migration out (243, 20.6%); frequent revisit (112, 9.5%); late migration out (219, 18.6%); and consistently living in the DTES (606, 51.4%). Compared with those who consistently lived in the DTES, participants in the early migration out group had lower hospitalisation events (adjusted rate ratio = 0.65; 95% confidence interval: 0.48-0.90). We found that PWUD who migrated out of the DTES early had lower hospitalisation events compared to those who consistently lived in the DTES, which may be a function of lesser addiction severity among this trajectory group. These findings underscore a need to provide transitional health and social service supports for other trajectory groups in an effort to minimise hospitalisation for preventable causes.
Identifiants
pubmed: 32485075
doi: 10.1111/dar.13095
pmc: PMC7864616
mid: NIHMS1665673
doi:
Substances chimiques
Illicit Drugs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
924-931Subventions
Organisme : NG Biomed Ltd
Pays : International
Organisme : MSFHR / St. Paul's Hospital Foundation-Providence Health Care Career Scholar Award
Pays : International
Organisme : NIDA NIH HHS
ID : U01 DA038886
Pays : United States
Organisme : CIHR
ID : MSH-141971
Pays : Canada
Organisme : NIDA NIH HHS
ID : U01 DA021525
Pays : United States
Organisme : St. Paul's Foundation
Pays : International
Organisme : University of British Columbia Doctoral Fellowship
Pays : International
Organisme : Tier 1 Canada Research Chair in Inner City Medicine
Pays : International
Organisme : NIDA NIH HHS
ID : R01 DA021525
Pays : United States
Informations de copyright
© 2020 Australasian Professional Society on Alcohol and other Drugs.
Références
Harm Reduct J. 2006 May 24;3:18
pubmed: 16723029
Drug Alcohol Depend. 2013 Oct 1;132(3):486-90
pubmed: 23587537
Neuroimage. 2003 Jul;19(3):1240-9
pubmed: 12880849
JAMA. 1998 Aug 12;280(6):547-9
pubmed: 9707146
J Subst Abuse Treat. 2019 Dec;107:17-23
pubmed: 31757260
Harm Reduct J. 2018 Mar 20;15(1):14
pubmed: 29558943
Addiction. 2010 Jun;105(6):991-1002
pubmed: 20659059
Psychol Addict Behav. 2005 Dec;19(4):339-51
pubmed: 16366806
Int J Drug Policy. 2015 Jul;26(7):645-52
pubmed: 25683138
Health Place. 2007 Jun;13(2):432-9
pubmed: 16798055
Drug Alcohol Depend. 2018 Aug 1;189:90-95
pubmed: 29894910
CMAJ. 2004 May 11;170(10):1551-6
pubmed: 15136548
Addiction. 1994 May;89(5):513-6
pubmed: 8044118
BMJ Open. 2016 Jan 06;6(1):e009043
pubmed: 26739726
Soc Sci Med. 2005 Sep;61(5):1026-44
pubmed: 15955404
J Urban Health. 2013 Jun;90(3):559-73
pubmed: 23161093
Drug Alcohol Depend. 2011 Jan 15;113(2-3):236-41
pubmed: 20889270
Clin Infect Dis. 2007 Nov 1;45(9):1200-3
pubmed: 17918083
Int J Drug Policy. 2007 Jan;18(1):27-36
pubmed: 17689341
Am J Epidemiol. 1993 Dec 1;138(11):923-36
pubmed: 8256780
Am J Epidemiol. 2011 Apr 1;173(7):829-36
pubmed: 21320867
MMWR Morb Mortal Wkly Rep. 2017 Jun 09;66(22):569-573
pubmed: 28594786
J Gen Intern Med. 2003 Apr;18(4):242-7
pubmed: 12709090
CMAJ. 2001 Aug 21;165(4):415-20
pubmed: 11531049